The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Outsourcing for one of the largest U.S. forest products manufacturers
Represented one of the largest U.S. forest products manufacturers in outsourcing of finance and accounting services. more
IRS audit of a leading aerospace systems supplier
Represented a leading aerospace systems supplier in an IRS audit involving over $500 million in proposed adjustments. The representation included more
Intellectual property protection for a non-profit health care organization
Serves as intellectual property counsel to a non-profit health care organization, including assisting in trademark enforcement, trademark protection more
Energy advice to a Swedish governmental body
Represented a Swedish governmental body on regulation of use of electricity grid.  The firm also negotiated with several industrial partners, more